The challenge for pharma companies: become a catalyst not a barrier

This 7th Access to Medicine Index was prepared amid the coronavirus pandemic which has thrown the chronic problem of inequitable access to medicine into sharp relief. Despite laudable moves by some pharmaceutical companies to curb profits to help fight the crisis, the stark reality is that billions of people living in low- and middle-income countries are still at the back of the queue for vaccines and treatments.

Explore further

Get in touch

Back to top |